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CASE REPORT
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Abstract 
Background: Pierson syndrome (PS) is a rare autosomal recessive disorder, caused by mutations in the laminin β2 
(LAMB2) gene. It is characterized by congenital nephrotic syndrome, microcoria, and neurodevelopmental deficits. 
Several mutations with genotype–phenotype correlations have been reported, often with great clinical variability. 
We hereby report a novel homozygous nonsense mutation in the LAMB2 gene, associated with a severe phenotype 
presentation.
Case diagnosis: We describe a term male infant born from consanguineous parents. The mother previously lost 
three children in the neonatal period, secondary to undefined renal disease, had two spontaneous abortions, and 
gave birth to one healthy daughter. The index case presented at birth with bilateral microcoria, severe hypotonia, 
respiratory distress, and congenital nephrotic syndrome associated with anuria and severe renal failure requiring 
peritoneal dialysis. The patients’ clinical follow-up was unfavorable, and the newborn died at 7 days of life, after with-
drawal of life support. Genetic analysis revealed a homozygous nonsense mutation at position c.2890C>T causing a 
premature stop codon (p.R964*) in LAMB2 gene.
Conclusion: We here describe a novel nonsense homozygous mutation in LAMB2 gene causing a severe neonatal 
presentation of Pierson syndrome. This new mutation expands the genotype–phenotype spectrum of this rare dis-
ease and confirms that truncating mutations might be associated with severe clinical features.
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Background
Pierson syndrome (PS) is a rare autosomal recessive dis-
ease, characterized by congenital nephrotic syndrome 
and progressive renal failure [1]. It can be also associated 
with ocular abnormalities and neurodevelopmental defi-
cits [1]. The incidence of PS remains unknown, although 
PS is recognized as the fourth most common cause of 
congenital nephrotic syndrome [2]. Affected individu-
als have mutations in the LAMB2 gene, coding for one 
of several extracellular glycoproteins expressed in the 
glomerular basement membrane, ocular structures, and 
the neuromuscular synapses [1].
We here report a novel homozygous nonsense muta-
tion at position c.2890C>T in the LAMB2 gene causing a 
premature stop codon (p.R964*) in a newborn, associated 
with a severe phenotype presentation.
Case presentation
The mother of the index patient was 25 years old at the 
time of birth. Parents were consanguineous cousins. She 
previously had six pregnancies, but lost all of them except 
one (a healthy girl). Three of her previous infants died in 
Somalia from undefined renal disease (two girls in the 
immediate neonatal period, and one boy at 1  month of 
age). The mother also had two spontaneous abortions 
Open Access
European Journal
of Medical Research
*Correspondence:  boutaina.zemrani@chuv.ch 
1 Division of Pediatric Nephrology, Department of Pediatrics, Lausanne 
University Hospital, Rue du Bugnon 46, 1011 Lausanne, Switzerland
Full list of author information is available at the end of the article
Page 2 of 4Zemrani et al. Eur J Med Res  (2016) 21:19 
(Fig. 1). Current pregnancy was complicated by bilateral 
hydronephrosis in the fetus, diagnosed at 22  weeks of 
gestation. Prenatal ultrasounds revealed hyperechogenic 
kidneys, associated with oligohydramnios at 32 weeks of 
gestation, and anamnios at 34 weeks of gestation requir-
ing a C-section. At birth, the index patient presented 
with severe respiratory distress and persistent pulmonary 
hypertension requiring mechanical ventilation. Physi-
cal exam was remarkable for severe hypotonia and bilat-
eral microcoria (Fig.  2). Birth weight, length, and head 
circumference were 2380  g (P10-50), 46.5  cm (P10-50), 
and 31  cm (P10-50), respectively. Placental weight was 
840 g (>P97). Laboratory investigations revealed a severe 
nephrotic range proteinuria with acute renal failure [total 
plasma protein 30 g/l (reference range 46–70 g/l), albu-
min 16  g/l (reference range 26–36  g/l), urine protein 
58.5  g/l (reference range ≤0.15  g/l), and plasma creati-
nine 300 μmol/l (reference range 17.7–88.4 umol/l)]. Per-
itoneal dialysis was initiated with daily albumin infusions. 
Renal ultrasonography showed enlarged hyperechogenic 
kidneys with a poor corticomedullary differentiation.
On the basis of the physical examination and clinical 
presentation, Pierson syndrome was suspected. Genetic 
analysis was performed in the Blueprint Genetics labo-
ratory in Finland, using “the Nephrotic syndrome panel” 
which covers nine genes with a strong association with 
this disorder. Pierson syndrome was confirmed, with 
a novel homozygous nonsense mutation c.2890C>T 
(p.R964*) in the LAMB2 gene. Due to the dismal progno-
sis, life support treatment was withdrawn, and the infant 
died at 7 days of life.
Discussion
PS was first described in 1963 by Michel Pierson [1, 3, 
4]. It is caused by mutations in the LAMB2 gene. It’s a 
rare disease with only around 50 mutations from about 
40 unrelated families identified so far [1]. Recently, sev-
eral novel mutations in LAMB2 gene that expand the 
clinical spectrum of LAMB2-associated disorders have 
been described [1, 2, 5–8]. Disease-causing mutations 
comprise missense, nonsense, and splice-site mutations, 
as well as small deletions and insertions, found either 
as homozygous or compound heterozygous. Truncat-
ing mutations are associated with severe disease. How-
ever, nontruncating LAMB2 mutations result in partial 
expression of laminin β2, causing less severe phenotype, 
resulting in some residual function of the gene [9, 10] and 
milder or atypical phenotypes [1, 2, 8, 9].
Kidney involvement in PS seems to be a universal pres-
entation, with variable degrees of severity [8], ranging 
Fig. 1 Genealogical tree of the family: Parents are first-cousins; three sibs of the proband died in the neonatal period and were probably affected 
by Pierson’s syndrome
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from a minor podocyte effacement to a diffuse mesan-
gial sclerosis with crescentic formation [2]. Of note, renal 
involvement can be present before birth, as in our case, 
or appear later in life.
Ocular involvement is also an important finding in 
PS, the most ocular anomaly being microcoria. Other 
ocular abnormalities have been described, such as iris 
anomalies, abnormal lens shape with cataracts, retinal 
abnormalities or high-grade myopia [4, 6, 11, 12]. Ocu-
lar anomalies are not universal in PS patients. They can 
even be lacking  [11], as it seems that only little residual 
function of LAMB2 is required for normal development 
of iris muscles [2].
Many patients with PS show severe neurodevelopmen-
tal deficits and muscular weakness [13]; however, simi-
lar to the eye involvement, patients with truncating or 
splice-site mutations on each allele can present normal 
neurologic and cognitive development [6, 8, 13].
Current data suggest the presence of significant gen-
otype–phenotype correlations [4, 12]. In fact, some 
authors have shown that patients with mild phenotypes 
(including minor glomerular changes or focal and seg-
mental glomerulosclerosis) harbor at least one missense 
or nontruncating deletion mutation, whereas patients 
with more severe phenotypes (including mesangial scle-
rosis, severe renal symptoms or end-stage renal disease 
in the first year of life) have truncating mutations [1, 4, 8, 
12, 14]. However, recent reports show that patients with 
truncating mutations do not always harbor such severe 
features: two Asian subjects with bi-allelic truncated 
mutations kept a normal renal function until 3 and 6 years 
of age [6, 15]. Our patient has a nonsense mutation, 
resulting in a premature truncation of laminin β2 (stop 
codon after 964 residues out of 1798). It caused a severe 
phenotype, leading to end-stage renal failure in the early 
neonatal period. This mutation is reported for the first 
time in a homozygous state. According to EXAC data-
base (http://www.exac.broadinstitute.org/August 2015), 
there’s one similar mutation (R964*) in a heterozygote 
pattern found using a genomic sequencing in 60,000 
individuals. The prevalence of heterozygous truncating 
mutations in the EXAC database is about 1/1000 person, 
leading to a probability of 1 over 4 million to have a PS 
with a truncating mutation. PS has rarely been described 
in African subjects [1]. Although ethnicity might play a 
role, this is most likely secondary to underdiagnoses of 
PS in Africa.
Conclusion
Clinical spectrum of LAMB2-associated disorders var-
ies from mild-to-severe ocular, renal, and neurologic 
involvement. This case adds to the literature a severe and 
fatal neonatal form of PS secondary to a newly nonsense 
homozygous mutation in the LAMB2 gene. This new 
mutation expands the genotype–phenotype spectrum of 
this rare disease and confirms that truncating mutations 
might be associated with a severe clinical phenotype.
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